Search research articles
Contact Us
Filters
Showing results (1-10 of 101) with videos related to
Page
of 11
Sort By:
Hepatology (Baltimore, Md.)
|
July 29, 2025
Reply: Is fecal acetate a viable pan-etiological predictor of outcomes in HCC immunotherapy?
Pei-Chang Lee, Yi-Hsiang Huang
Foods (Basel, Switzerland)
|
July 12, 2025
Impact of Fatty Acid Types and Microwave Post-Treatment on the Physicochemical Properties of Water Caltrop Starch-Lipid Complexes
Pei-Chang Lee, Lih-Shiuh Lai
Translational Gastroenterology and Hepatology
|
February 12, 2026
Integration of local and systemic immunotherapy: setting new standards in liver-confined hepatocellular carcinoma
Pei-Chang Lee, Yi-Hsiang Huang, David James Pinato
The American Journal of the Medical Sciences
|
April 15, 2020
Staghorn Renal Stone With Magnesium Ammonium Phosphates Crystals
Yi-An Hu, Pei-Chang Lee, Szu-Yuan Li
Journal of the Chinese Medical Association : JCMA
|
December 27, 2024
Effect of immune checkpoint inhibitors on patients with hepatitis B virus infection
Hsien-Chen Mon, Pei-Chang Lee, Chen-Ta Chi, et al.
Scientific Reports
|
October 28, 2020
Pre-sarcopenia determines post-progression outcomes in advanced hepatocellular carcinoma after sorafenib failure
Tsung-Yi Cheng, Pei-Chang Lee, Yi-Tzen Chen, et al.
JHEP Reports : Innovation in Hepatology
|
August 21, 2025
Serum fibrosis marker M2BPGi-based novel score predicts survival of unresectable HCC undergoing immunotherapy
Pei-Chang Lee, Chi-Jung Wu, I-Cheng Lee, et al.
BMC Gastroenterology
|
July 12, 2023
Triage policy to postpone endoscopy for patients with low-risk varices is safe during the lockdown period of COVID-19 pandemic
Yu-Jen Chen, Ming-Chih Hou, Tsung-Chieh Yang, et al.
The American Journal of Gastroenterology
|
August 6, 2023
A Randomized Controlled Trial of Propranolol Use During Ligation Program for Secondary Prophylaxis of Esophageal Variceal Bleeding
Wen-Chi Chen, Tsung-Chieh Yang, Pei-Chang Lee, et al.
Journal for Immunotherapy of Cancer
|
September 1, 2020
Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma
Pei-Chang Lee, Yee Chao, Ming-Huang Chen, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 101) with videos related to
Sort By:
Page
of 11
Hepatology (Baltimore, Md.)
|
July 29, 2025
Reply: Is fecal acetate a viable pan-etiological predictor of outcomes in HCC immunotherapy?
Pei-Chang Lee, Yi-Hsiang Huang
Foods (Basel, Switzerland)
|
July 12, 2025
Impact of Fatty Acid Types and Microwave Post-Treatment on the Physicochemical Properties of Water Caltrop Starch-Lipid Complexes
Pei-Chang Lee, Lih-Shiuh Lai
Translational Gastroenterology and Hepatology
|
February 12, 2026
Integration of local and systemic immunotherapy: setting new standards in liver-confined hepatocellular carcinoma
Pei-Chang Lee, Yi-Hsiang Huang, David James Pinato
The American Journal of the Medical Sciences
|
April 15, 2020
Staghorn Renal Stone With Magnesium Ammonium Phosphates Crystals
Yi-An Hu, Pei-Chang Lee, Szu-Yuan Li
Journal of the Chinese Medical Association : JCMA
|
December 27, 2024
Effect of immune checkpoint inhibitors on patients with hepatitis B virus infection
Hsien-Chen Mon, Pei-Chang Lee, Chen-Ta Chi, et al.
Scientific Reports
|
October 28, 2020
Pre-sarcopenia determines post-progression outcomes in advanced hepatocellular carcinoma after sorafenib failure
Tsung-Yi Cheng, Pei-Chang Lee, Yi-Tzen Chen, et al.
JHEP Reports : Innovation in Hepatology
|
August 21, 2025
Serum fibrosis marker M2BPGi-based novel score predicts survival of unresectable HCC undergoing immunotherapy
Pei-Chang Lee, Chi-Jung Wu, I-Cheng Lee, et al.
BMC Gastroenterology
|
July 12, 2023
Triage policy to postpone endoscopy for patients with low-risk varices is safe during the lockdown period of COVID-19 pandemic
Yu-Jen Chen, Ming-Chih Hou, Tsung-Chieh Yang, et al.
The American Journal of Gastroenterology
|
August 6, 2023
A Randomized Controlled Trial of Propranolol Use During Ligation Program for Secondary Prophylaxis of Esophageal Variceal Bleeding
Wen-Chi Chen, Tsung-Chieh Yang, Pei-Chang Lee, et al.
Journal for Immunotherapy of Cancer
|
September 1, 2020
Risk of HBV reactivation in patients with immune checkpoint inhibitor-treated unresectable hepatocellular carcinoma
Pei-Chang Lee, Yee Chao, Ming-Huang Chen, et al.
Page
of 11